Receptor for hyaluronan-mediated motility (RHAMM) defines an invasive niche associated with tumor progression and predicts poor outcomes in breast cancer patients.
Tarullo SE, He Y, Daughters C, Knutson TP, Henzler CM, Price MA, Shanley R, Witschen P, Tolg C, Kaspar RE, Hallstrom C, Gittsovich L, Sulciner ML, Zhang X, Forster CL, Lange CA, Shats O, Desler M, Cowan KH, Yee D, Schwertfeger KL, Turley EA, McCarthy JB, Nelson AC.
Tarullo SE, et al. Among authors: he y.
J Pathol. 2023 Jul;260(3):289-303. doi: 10.1002/path.6082. Epub 2023 Apr 26.
J Pathol. 2023.
PMID: 37186300
Free PMC article.